Clinical Trial Update: Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy [Phase 1]

View source ↗

Summary

Phase I study evaluating gefitinib (Iressa) in combination with CRT/IMRT in Chinese patients with IIIB/IV non-small cell lung cancer after platinum-based chemot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Iressa (gefitinib)

Snippet

Sponsor: Fudan University | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1 | Status: UNKNOWN